Strategic Pathways to Commercialization for Emerging Biopharma Companies

Joe Magliocco outlines the key strategic pathways available to emerging pharma & biotech companies (commercializing on their own, out-licensing, partnering, or acquisition).

He discusses the factors that might push a company to choose one particular pathway over another, what pathway the "typical" company follows, and why a company might choose to deviate from the "typical" path. This is video #3 in our series on "Make or Break" factors for emerging biopharma companies.

[saaarahc]

Highly informative! Thank you for sharing this info 👍